Buy the Brand or Buy the Rep? Offerings for Both Types of Orthopedic Customers

Posted by Tobi Laczkowski on May 4, 2015

One of the areas of increasing scrutiny within the medtech world in recent months has been the recognition that the selling expense, often masked within a company’s SG&A (selling, general and administrative expense), is higher within medtech than most other industries.


>
Read More

Why Delaying Surgery Can Be Big Business

Posted by Matt Scheitlin on April 13, 2015

Orthopedics has been one of the great medtech success stories of the past 50 years. The transformative joint-replacement procedures and technology have mitigated enormous sources of pain and restored mobility in patients—with all of the cardiovascular, weight control and associated health benefits included.


>
Read More

Don’t Forget the Patient

Posted by Andy Kach on April 7, 2015

With the increased commoditization of products and the rapidly increasing “fast follower” environment in medical devices, manufacturers are struggling to find the differentiating value they can bring to their primary customers, health-care providers. While millions of dollars are spent researching what makes a doctor tick, many manufacturers may be missing a significant driver of value for health-care providers.


>
Read More